Penicillin as empirical therapy for patients hospitalised with community acquired pneumonia at a Danish hospital

Danish Medical Bulletin

Volumn 48, Issue 2, 2001, Pages 84-88

  Kirk, Ole ^a   Glenthoj, Jonathan ^a   Drags Ted, Ulrik B ^a   Hehveg Larsen, Jannik ^a   Am, Thomas M ^a   Benfield, Thomas L ^a   Jensen, Klaus ^a   Vestbo, Jörgen ^a   Lundgren, Jens D ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; DENMARK; FEMALE; HOSPITAL PATIENT; HUMAN; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; MYCOPLASMA PNEUMONIAE; PNEUMONIA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; DENMARK; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PENICILLINS; PNEUMONIA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0034998494     PISSN: 09078916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Niederman MS, Bass Jr JB, Campbell GB et al. Guidelines for initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148:1418-26.
2. Bartlett JG, Breiman RF, Mandell LA et al. Community-acquired pneumonia in adults: guidelines for management. CID 1998; 26: 811-38.
3. Macfarlane J. An Overview of community acquired pneumonia with lessons learned from the British Thoracic Society study. Semin Respir Infect 1994; 9: 153-65.
4. Mandell LA. Community-acquired pneumonia, etiology, epidemiology, and treatment. Chest 1995; 108: 35S-42S.
5. Niederman MS. Empirical therapy of community-acquired pneumonia. Semin Respir Infect 1994; 9: 192-8.
6. Örtqvist A. Initial investigation and treatment of the patient with severe community-acquired pneumonia. Semin Respir Infect 1994; 9: 166-79.
7. The British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. B J Hosp Med 1993; 49: 346-50.
8. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995; 333: 1618-24.
9. Leroy O, Santré C, Beuscart CC et al. A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 1995; 21: 24-31.
10. Kauppinen MT, Herva E, Kujala P et al. The etiology of community-ac-quired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. J Infect Dis 1995; 172: 1330-5.
11. Levy M, Dromer F, Brion N et al. Community-acquired pneumonia. Importance of initial noninvasive bactériologie and radiographie investigations. Chest 1988; 92:43-8.
12. Bohte R, van Furth R, van den Broek PJ. Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. Thorax 1995; 50: 543-7.
13. Fang GD, Fine M, Orloff J et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine 1990: 307-16.
14. Riquelme R, Torres A, El-Ebiary M et al. Community-acquired pneumonia in the elderly. A multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med 1996; 144: 1450-5.
15. Nielsen SV, Poulsen K, Jorgensen LM et al. Incidens og diagnostik af indteggelseskrxvende pneumonier foràrsaget af pneumokokker. Ugeskr Lger 1992; 154: 1-4.
16. Lister PD. Multi-resistant Pneumococcus: therapeutic problems in the management of serious infections. Eur J Clin Microbiol Infect Dis 1995; (suppl)l: 18-25.
17. McGowan JE, Metchock BG Penicillin-resistant pneumococci -an emerging threat to successful therapy. J Hosp Infect 1995; 30:472-82 (suppl).
18. Ekdahl K, Kamme C. Increasing resistance to penicillin in Streptococcus pneumoniae in Southern Sweden. Scand J Infect Dis I994; 26: 301-5.
19. Gordon GS, Throop D, Berberian L et al. Validation of the therapeutic recommendations of the American Thoracic Society (ATS) guidelines for community acquired pneumonia in hospitalized patients (abstract). Chest 1996; 110:555 (suppl).
20. Mundy LM, Auwaerter PG, Oldach D et al. Community-acquired pneumonia: impact of immune status. Am J Respir Crit Care Med 1995; 152: 1309-15.
21. Fine MJ, Smith MA, Carson ÇA et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996; 275: 134-41.
22. The British Thoracic Society Research Committee and The Public Health Laboratory Service. The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit. Resp Med 1992; 86: 7-13.
23. Örtqvist A. Prognosis in community-acquired pneumonia requiring treatment in hospital. Importance of predisposing and complicating factors, and of diagnostic procedures. Scand J Infect Dis 1990; 65: 1-62 (suppl).
24. Hedlund, J. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short- and long-term prognosis. Scand J Infect Dis 1995; 97: 1-60 (suppl).
25. Brown PD, Lerner SA. Community-acquired pneumonia. Lancet 1998; 352: 1295-302.
26. Kemp M, Westh H, Scheibel JH. Penicillinresistente pneumokokker endnu ikke en trussel i Danmark? (Penicillin-resistant pneumococci not a threat in Denmark yet? Ugeskr Lseger 1998; 160: 622-5.